ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2015

Oct 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2015-10-28

Reporting Person: Clendeninn Neil James (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-28	Common Stock	M	5359	$2.69	Acquired	19921	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-28	Stock Option (right to buy)	$2.69	M	5359	Disposed	2015-10-28	Common Stock (5359)	Direct